Literature DB >> 5573607

Effects of depo-medroxyprogesterone acetate as a contraceptive agent.

L C Powell, R J Seymour.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5573607     DOI： 10.1016/0002-9378(71)90210-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  6 in total

1.  Use of medroxyprogesterone acetate as a contraceptive in conjunction with early postpartum rubella vaccination.

Authors:  D S Sharp; H Macdonald
Journal:  Br Med J       Date:  1973-11-24

Review 2.  Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

3.  Invasive cervical cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

Authors:  D B Thomas; L Noonan; A Whitehead; D Roseman
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

Review 4.  Long acting contraceptives. Present status.

Authors:  G Benagiano; F M Primiero
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

5.  Delayed postpartum sterilization.

Authors:  J Mowat
Journal:  Br Med J       Date:  1974-05-11

Review 6.  Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.